Join UCLA Biodesign in celebrating the graduation of the 2021-2022 Biodesign Fellows. The session will showcase pitches from the UCLA Biodesign Fellows and a keynote address by Dr. Nick West, Chief Medical Officer and Divisional Vice President of Global Medical Affairs of Abbott Vascular. The program will feature innovative product solutions spanning digital health, diagnostics, interventional devices, and technology-enabled health services, as well as opening remarks by Johnese Spisso, President of UCLA Health and CEO of UCLA Hospitals and Clinics, Dr. Steve Dubinett, Interim Dean of the David Geffen School of Medicine at UCLA and Antonio Bernardo, Dean of the UCLA Anderson School of Management.
Members of the UCLA community and the public are welcome to join in person at Tamkin Auditorium at Ronald Reagan UCLA Medical Center or via Zoom
REGISTER BELOW
In-Person: https://bit.ly/Biodesign-Grad-InPerson
Virtual: https://bit.ly/Biodesign-Grad-Virtual
Opening Remarks:
UCLA Anderson School of Management, David Geffen School of Medicine at UCLA, and UCLA Health Leaders: Antonio Bernardo, Dr. Steven M. Dubinett, Johnese Spisso
Keynote Speaker
Dr. Nick West, Chief Medical Officer & Divisional Vice President of Global Medical Affairs, Abbott Vascular
Speaker Bio
Dr. Nick West is the Chief Medical Officer and Divisional Vice President of Global Medical Affairs of Abbott’s vascular business, a global medical device company developing life-changing technologies to reduce the burden of cardiovascular disease and improve patients’ lives. He graduated in medicine from Trinity Hall, University of Cambridge and St. Thomas’ Hospital Medical School, London, and trained in interventional cardiology at the John Radcliffe Hospital, Oxford and Green Lane Hospital, Auckland, New Zealand. His postgraduate research in vascular biology, undertaken in the Department of Cardiovascular Medicine, University of Oxford and at Duke University, led to the award of the Sir Lionel Whitby Medal and the Sir Walter Langdon-Brown Prize at the University of Cambridge. Until late 2019 he was a practicing interventional cardiologist at the Royal Papworth Hospital, Cambridge, UK; he has published over 120 peer-reviewed papers & book chapters on topics including coronary physiology/microvascular function, intracoronary imaging/vulnerable plaque detection, acute myocardial infarction and use of bioresorbable scaffolds. He was also a founding member and latterly Chief Medical Officer of the Cambridge-based biotechnology startup, PlaqueTec Ltd.
About UCLA Biodesign
UCLA Biodesign is a catalyst for healthcare technology innovation, education, and translation. Uniting stakeholders across the healthcare ecosystem, UCLA Biodesign seeks to transform medicine through the development of novel technologies that address meaningful unmet needs and deliver improved value across the continuum of health and wellness. At the cornerstone of the program is the UCLA Biodesign Fellowship, a one-year postgraduate fellowship in healthcare technology innovation open to faculty, residents, and industry professionals in medicine, business, design, and engineering.
